SCHEMBL26435121

SCHEMBL26435121

c1cc(-c2nc(-c3cccc4c3oc3ccccc34)nc(-c3cccc4ccc5ccccc5c34)n2)cc(-c2cccc3oc4ccccc4c23)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.43
GGPS1 O95749 1/20 0.38
TDP1 Q9NUW8 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
PTGES2 Q9H7Z7 1/20 0.36
PRKDC P78527 4/20 0.34
PIK3CD O00329 1/20 0.34
PIK3CB P42338 1/20 0.34
ABCG2 Q9UNQ0 3/20 0.34
AHR P35869 2/20 0.34
CYP1A1 P04798 1/20 0.34
CYP1A2 P05177 1/20 0.34
FYN P06241 1/20 0.34
MAPK3 P27361 1/20 0.34
PAX8 Q06710 1/20 0.34
MAPT P10636 4/20 0.33
KDM4E B2RXH2 3/20 0.33
ALDH1A1 P00352 3/20 0.33
HPGD P15428 2/20 0.33
HSD17B10 Q99714 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26435476 1.00 ALOX5 (0.43) ALOX5GGPS1TDP1L3MBTL1PTGES2
SCHEMBL26435621 0.99 ALOX5 (0.44) ALOX5GGPS1TDP1L3MBTL1PTGES2
SCHEMBL26435521 0.97 ALOX5 (0.45) ALOX5GGPS1TDP1L3MBTL1PTGES2
SCHEMBL26435479 0.96 ALOX5 (0.46) ALOX5GGPS1TDP1L3MBTL1PTGES2
SCHEMBL26435150 0.95 ALOX5 (0.43) ALOX5GGPS1TDP1L3MBTL1PTGES2
SCHEMBL26435123 0.95 ALOX5 (0.48) ALOX5GGPS1TDP1L3MBTL1PTGES2
SCHEMBL26435623 0.95 ALOX5 (0.48) ALOX5GGPS1TDP1L3MBTL1PTGES2
SCHEMBL26435462 0.94 ALOX5 (0.44) ALOX5GGPS1TDP1L3MBTL1PTGES2
SCHEMBL26435662 0.94 ALOX5 (0.44) ALOX5GGPS1TDP1L3MBTL1PTGES2
SCHEMBL26435630 0.93 ALOX5 (0.46) ALOX5GGPS1TDP1L3MBTL1PTGES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS NOM1, MNS1, NOS1 ALOX5 1266/4885GGPS1 1604/4885TDP1 1017/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.